Clinical Trial Update: Efficacy of PERT for PEI in Unresectable Pancreatic Cancer. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency in patients with unres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pancreatic enzyme replacement therapy (PERT) (pancreatic enzyme replacement therapy)

Snippet

Sponsor: Hospital Clinico Universitario de Santiago | Conditions: Unresectable Pancreatic Cancer | Phase 4 | Status: RECRUITING